Screener
Bio-Rad Laboratories BIO Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Bio-Rad Laboratories’s 10-K, filed February 13, 2026.
- Filed
- Feb 12, 2026, 9:50 PM EST
- Fiscal year
- FY2025
- Accession
- 0000012208-26-000010
| Line item | December 31, 2025 | December 31, 2024 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $529.8 | $488.1 |
| Short-term investments | 1,010.9 | 1,176.4 |
| Accounts receivable, less allowance for credit losses of $5.5 and $9.2 as of December 31, 2025 and 2024, respectively | 460.6 | 452.5 |
| Inventory | 740.7 | 760.0 |
| Prepaid expenses | 136.5 | 122.6 |
| Other current assets | 27.7 | 30.7 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Bio-Rad Laboratories's short-term investments?
- Bio-Rad Laboratories (BIO) reported short-term investments of $1.01B in Q4 2025.
- What is the long-term trend for Bio-Rad Laboratories's short-term investments?
- Over 3 years (2022 to 2025), Bio-Rad Laboratories's short-term investments has grown at a -9.3% compound annual growth rate (CAGR), from $1.36B to $1.01B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Bio-Rad Laboratories's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude